AbNativ Method: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering

AbNatiV is a deep learning tool for assessing the nativeness of antibodies and nanobodies, that is, their likelihood of belonging to the distribution of immune-system-derived human antibodies or camelid nanobodies.
Technology No. SOR-10896-24

AbNatiV is a multipurpose tool that accurately predicts the nativeness of Fv sequences from any source, including synthetic libraries and computational design. It provides an interpretable score that predicts the likelihood of immunogenicity, and a residue-level profile that can guide the engineering of antibodies and nanobodies indistinguishable from immunesystem-derived ones. We further introduce an automated humanization pipeline, which can be applied to nanobodies and traditional (VH/VL) Fv regions. Immune-system-derived antibodies tend to have favourable properties in vivo, including long half-life, low reactivity with selfantigens and low toxicity, thus underscoring the importance of nativeness predictions and optimisation

  • expand_more cloud_download Supporting documents (1)
    Product brochure
    AbNativ Method: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering.pdf
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
1-Year, Single-User, Single-Site Commercial Licence
Non-exclusive and non-transferable licence, for internal use only, for any user within the User Definition to install, load, display, run and make necessary back-up copies of the Software for the term.

Term: 1 year

Price per unit:
From £1,200.00 excl. VAT

Sign up to our newsletter

If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.